Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 6 Issue 1

Bio-Reset and Complete Treatment of Chronic Glaucoma Center for General Informational Regenerative Medicine and Ophthalmology

Massimo Lombardi*

Ophthalmologist - Regenerative Medicine Specialist, Lombardi-Eye-Clinic, Rome, Italy

*Corresponding Author: Massimo Lombardi, Ophthalmologist - Regenerative Medicine Specialist, Lombardi-Eye-Clinic, Rome, Italy.

Received: November 30, 2022; Published: December 20, 2022

Abstract

Presentation: It is necessary to “Re-Formulate” -in Toto- “the Clinical Perspective of Glaucoma” since it has been focused “mostly" on the "Control of intra-Ocular Pressure Rise" caused by a "Progressive Increasing Resistance to Water Mood’ Outflow" in "Schlemm's Canal Trabeculate”.

A "Reductive and Myopic Vision of the Problem" which, in fact, has allowed "in the last centuries" "superficial and erroneous -Scientific- Thinking" unable to understand the "True Reasons" and not only the "Consequences" of the well known Clinical Phenomenon, that the Progressive Increase in Ocular Pressure inevitably leads to an inexorably worsening of visual functions as the: Visual Field, Visual Ability and Acuity, Color Vision, Contrast Sensitivity and Night Vision, up to a "Progressive Blindness'".

Keywords: Chronic Glaucoma; Collagen; Lamina Cribrosa

References

  1. Massimo Lombardi. “Retinal Stem Cells Reprogramming". Journal of Ophthalmology and Clinical Research (2018).
  2. Massimo Lombardi. “Retinal Stem Cells Reprogramming Using Homotoxicological Pharmaceuticals Blend Therapy through Retrobulbar Injections". Journal of Stem Cells Research (2018).
  3. Massimo Lombardi. “Retinal and Body' Stem Cells Reprogramming”. Acta Scientific Ophthalmology6 (2021).
  4. Massimo Lombardi. “Biological Reset and Chronic Glaucoma Healing”. Acta Scientific Ophthalmology12 (2021).

Citation

Citation: Massimo Lombardi. “Bio-Reset and Complete Treatment of Chronic Glaucoma Center for General Informational Regenerative Medicine and Ophthalmology".Acta Scientific Ophthalmology 6.1 (2023): 19-28.

Copyright

Copyright: © 2022 Massimo Lombardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US